Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Financial Flexibility Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Financial Flexibility Index of 0.62x as of September 2025. Free cash flow of CN¥51.39 Million (operating CF CN¥21.03 Million minus capex CN¥30.36 Million) represents 1% of total liabilities (CN¥82.76 Million). Check 688091 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. See working capital to net assets of Shanghai Yizhong Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Shanghai Yizhong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 688091 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.78x | CN¥119.47 Million | CN¥39.44 Million | CN¥42.97 Million | ▲ +216.5% |
| 2023 | 0.88x | CN¥95.34 Million | CN¥86.55 Million | CN¥108.52 Million | ▼ -78.8% |
| 2022 | 4.14x | CN¥146.67 Million | CN¥110.78 Million | CN¥35.42 Million | ▲ +327.0% |
| 2021 | -1.82x | CN¥-45.64 Million | CN¥-48.78 Million | CN¥25.02 Million | ▼ -83.6% |
| 2020 | -0.99x | CN¥-15.21 Million | CN¥-20.21 Million | CN¥15.30 Million | ▼ -151.5% |
| 2019 | 1.93x | CN¥23.67 Million | CN¥-23.91 Million | CN¥12.26 Million | ▲ +558.4% |
| 2018 | -0.42x | CN¥-7.22 Million | CN¥-10.68 Million | CN¥17.15 Million | ▲ +34.4% |
| 2017 | -0.64x | CN¥-10.38 Million | CN¥-11.51 Million | CN¥16.17 Million | — |